{"id":"NCT02776683","sponsor":"Boehringer Ingelheim","briefTitle":"Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer","officialTitle":"A Single Arm, Open-label, Multicenter, Multinational, Safety and Efficacy Phase IIIb Trial of BI 695502 Plus mFOLFOX6 in Patients With Previously Untreated Metastatic Colorectal Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-06-08","primaryCompletion":"2018-10-03","completion":"2018-10-03","firstPosted":"2016-05-18","resultsPosted":"2019-11-21","lastUpdate":"2019-11-21"},"enrollment":123,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Colorectal Neoplasms"],"interventions":[{"type":"DRUG","name":"BI 695502","otherNames":[]},{"type":"DRUG","name":"Avastin","otherNames":[]}],"arms":[{"label":"All patients","type":"EXPERIMENTAL"}],"summary":"The objective of this trial is to evaluate the safety and tolerability of BI 695502 in combination with leucovorin/5-fluorouracil/oxaliplatin (mFOLFOX6) and as maintenance therapy (when applicable). As well as to evaluate the following efficacy parameters: Progression-free survival (PFS), objective response rate (proportion of patients with complete response \\[CR\\] plus partial response \\[PR\\]), overall survival (OS), duration of response (DOR), time to progression (TTP).","primaryOutcome":{"measure":"Percentage of Patients With Treatment-Emergent Adverse Events (TEAEs) in the Specified Categories Selected for Primary Endpoint Assessment","timeFrame":"From baseline up to 18 weeks after the last dose of trial medication prior to the Switch Visit. Maximum duration of up to 32 treatment cycles + safety follow up (up to 82 weeks overall).","effectByArm":[{"arm":"BI 695502","deltaMin":58.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":46,"countries":["United States","Japan","Spain","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":33,"n":123},"commonTop":["Nausea","Fatigue","Peripheral sensory neuropathy","Diarrhoea","Stomatitis"]}}